Biogen Idec 2005

Download Report

Transcript Biogen Idec 2005

BIOGEN IDEC FRANCE
BEST IN FRANCE
December 2004
Group C – ES1
Charles Najjar
Jonathan Newell
Gaku Susai
Jaime Arango
Agenda

Biogen Idec in the world
 R&D
 Product pipeline
 Biogen Idec France
 Company Values
 HR Difficulties in France and Adaptation to France
 Attraction and Retention of Talent
 Benefits and Costs
Biogen Idec Inc.








US Biotechnology company based in Cambridge, Mass.
Third largest Biotechnology company in the world
Result of a merger of equals in November 2003 between
Biogen Inc. and Idec Corp.
Core business: Oncology and Immunology
5 Products in the Market in the US (Tysabri approved by the
FDA in November ’04)
Sales over $2bn, 4.000 employees worldwide
Quoted in Nasdaq: BIIB ($20bn Market Cap)
Annual Growth estimated about 20% year/year
Worldwide Presence










Cambridge, MA: Biogen Idec Worldwide Headquarters
San Diego, CA: Biogen Idec Research, Manufacturing,
Commercial Capabilities
Research Triangle Park, North Carolina: Manufacturing
Washington, DC: Biogen Idec Government Relations
Canada: Direct Sales Force and Operations
Europe: Direct Sales Force & Operations in 13 Countries
Zug, Switzerland: International Headquarters
Netherlands: Packaging Facility
Japan: Developing Commercial Capabilities
Australia/NZ: Direct Sales Force
Research and Development


Research and Development only done in 2 centers
of excellence: Cambridge and San Diego in the US.
Manufacturing sites only in the US:
– Cambridge, Massachusetts
– RTP, North Carolina
– Oceanside, California

Biogen Idec is currently constructing a
manufacturing site in Denmark. It is expected to be
ready by 2007.
Product Pipeline
Company's clients

Vision
“With passion, purpose and partnerships, we transform
scientific discoveries into advances in human healthcare.”

Mission
“We create new standards of care in oncology and
immunology through our pioneering research, and our
global development, manufacturing and commercial
capabilities.”

Company tag-line: transforming discovery into care.
Biogen Idec France







Only 1 Product approved in France (Avonex®)
Over 42% market share in Multiple Sclerosis
market in 2004
Tysabri® is next product in MS expected to be
approved for commercialization in 2006
Amevive® in Phase 3 in Europe
Commercial rights of Rituxan® and Zevalin® were
given to third parties for sales outside the US
Sales over €80m, 65 employees
Teams built up to support local sales and marketing
Back in 1996…


Biogen decided to come to Europe to enlarge its
operations based at that moment on the US only.
France was one of the first countries to come.
Why?
 France is second largest MS market in Europe, only
behind Germany.
 Developed Social Security system.
 Developed infrastructure.
Company values

Courageous Innovation
We apply our knowledge, talent and resources to yield new insights and bold ideas. We confront challenge and
uncertainty with zeal, tenacity and vision and seize opportunities to excel.

Quality, Integrity, Honesty
Our products are of the highest quality. Our personal and corporate actions are rooted in mutual trust and
responsibility. We are truthful, respectful and objective in conducting business and in building relationships.

Team as a Source of Strength
Our company is strong because our employees are diverse, skillful and collaborative. We pursue our fullest
potential as individual contributors, team members and team leaders.

Commitment to Those We Serve
We measure our success by how well we enable people to achieve and to thrive. Patients, caregivers,
shareholders and colleagues deserve our best.

Growth, Transformation and Renewal
Consistent with our core values, we as individuals and as a corporation are dedicated to creative and
constructive growth, transformation and renewal as a source of inspiration and vitality.
Company values




Company values are general and applied
worldwide.
It is a company culture.
And the company seeks people that fits with this
culture.
Nevertheless these company values are difficult to
translate to French.
HR Difficulties in France
Before coming:
 The perception from the US towards France:
Rules and administration are complicated in France:
holidays, 35-hour week, contracts, taxes…
To keep in mind:
 Beware of laws – use lawyer frequently.
 Understanding of rules in France is very important – the
company can’t afford a mistake.
 Important for dealing with employees, works council and
trade unions.
Adaptation to France





Biogen Idec has worldwide rules and guidelines for
recruitment, compensation, performance appraisal, etc.
To make impact, communication has to be adapted to local
culture (i.e. performance appraisal).
Recruitment is very important in France, because of the size
of the company.
Also, every employee is actively participating in the
development of the company.
Generally, lay-off process in France is more complicated
than the US.
Attract and Retain Talent



Attract talent is easy for Biogen Idec: people are team
oriented, interested by the environment of a small company,
and have high scientific interest.
Retention and motivation come from the team spirit and the
job interest.
However, the size of the company in Europe limits
European transfers within the company.
Key Benefits






Because Biogen Idec France only has sales and marketing
efforts (no R&D nor Manufacturing), Revenue/employee
figures are high.
Infrastructure, quality of life and local work environment
are very positive, so the employee turnover is very low.
Pharmaceutical associations and pharmaceutical companies
in France facilitate interaction with governmental
organizations.
Social Security in France is one of the best in the world.
MS Market is the second most important market in Europe.
The company will increase its competitive advantage when
it will launch Tysabri® in 2006.
Key Costs






Salaries are lower, but taxes, benefits and charges are higher than
many other countries.
Because of the good infrastructure in France, travel, communications,
etc, are available for all the companies.
Also, because of the profile of employees sought, French employees
adapt to BI France culture and therefore to the company culture.
English is used throughout the company worldwide and is essential for
French employees, except for sales team.
Training is outsourced for employees when special knowledge is
required for the job.
Team meetings are developed in Europe for similar jobs and for
integration.
Essential Advice




Know the legislation and seek legal advice.
The company needs global and adaptable values,
with a common vision.
Seek the employees that can adapt to this culture.
When seeking presence in Europe, France is a
perfect starting point of operations.
We thank:
 Costanza Gadda-Conti - HR Manager France
[email protected]; Tel: 0141379595
For further information, please visit
www.biogenidec.com / www.biogenidec.fr